Shares of Viking Therapeutics VKTX gained more than 11% on Wednesday after the company announced that it had signed a broad ...

Medically reviewed by Qin Rao, MD Metabolic dysfunction-associated steatohepatitis (MASH)—previously known as nonalcoholic ...

Add articles to your saved list and come back to them any time. Peter Nash was only two years old in 1935 when his father, first class constable Leslie Andrew Nash, was discovered dead in the ...

Novartis has added another non-alcoholic steatohepatitis (NASH) drug candidate to its pipeline via an $80 million licensing deal with US biotech Pliant Therapeutics. The agreement focuses on PLN ...

There is no medication specifically for intrusive thoughts, but drugs that alleviate the underlying cause may also reduce the intrusive thoughts. Various conditions can cause intrusive thoughts ...

ED is most often treated with lifestyle changes and medications. In 1998, the Food and Drug Administration (FDA) approved Viagra, the first medication to treat ED. Viagra works by helping the ...

Results: KEGG enrichment analysis indicated that the NF-kappa B and TNF signaling pathways may be associated with COPD and NASH co-morbidities. Ten small-molecule drugs associated with COPD and NASH ...

Doctors refer to hair loss that occurs as a side effect of medication as drug-induced alopecia. Hair loss can be a side effect of many different medications, such as those for chemotherapy.

During the quarter, the company generated total revenues of $103.3 million entirely from product sales of its metabolic dysfunction-associated steatohepatitis (MASH) drug Rezdiffra (resmetirom ...

In 2020, Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Four years later, she and her husband, Ken, halted the treatment.

The first line of pharmacological treatment for schizophrenia is antipsychotic medication. However, antipsychotic medications are ineffective in more than 30% of people with the disorder. This is ...

Viking plans to advance the drug into phase 3 clinical studies in ... (MASH), which is also known as nonalcoholic steatohepatitis (NASH). As they say on the infomercials, "But wait!